Direct Cardiac Reprogramming - Converting Cardiac Fibroblasts to Cardiomyocytes
- PMID: 33693102
- PMCID: PMC7897695
- DOI: 10.1253/circrep.CR-19-0104
Direct Cardiac Reprogramming - Converting Cardiac Fibroblasts to Cardiomyocytes
Abstract
Cardiovascular disease is the leading cause of death and disability worldwide. Despite advances in cardiovascular therapy, mortality in heart disease still remains high. Direct cardiac reprogramming is a promising approach for cardiac tissue repair involving in situ generation of new cardiomyocytes from endogenous cardiac fibroblasts. Although, initially, the reprogramming efficiency was low, several developments in reprogramming methods have improved the in vitro cardiac reprogramming efficiency. Subsequently, in vivo cardiac reprogramming has demonstrated improvement in cardiac function and fibrosis after myocardial infarction. Here, we review recent progress in cardiac reprogramming as a new technology for cardiac regeneration.
Keywords: Cardiomyocyte; Direct reprogramming; Fibroblast; Regeneration.
Copyright © 2019, THE JAPANESE CIRCULATION SOCIETY.
Conflict of interest statement
T.S. declares no conflicts of interest.
Figures
References
-
- Furtado MB, Nim HT, Boyd SE, Rosenthal NA.. View from the heart: Cardiac fibroblasts in development, scarring and regeneration. Development 2016; 143: 387–397. - PubMed
-
- Yoshida Y, Yamanaka S.. Induced pluripotent stem cells 10 years later: For cardiac applications. Circ Res 2017; 120: 1958–1968. - PubMed
-
- Takahashi K, Yamanaka S.. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663–676. - PubMed
-
- Sadahiro T, Yamanaka S, Ieda M.. Direct cardiac reprogramming: Progress and challenges in basic biology and clinical applications. Circ Res 2015; 116: 1378–1391. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources